November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

Two blood tests currently in development have shown 'very high accuracy' in detecting tell-tale signs of Alzheimer's disease, ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

Frailty is a strong predictor of dementia risk, with risk increasing by 40% with each 4-5 additional age-related health conditions.

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Two new blood tests to diagnose Alzheimer's are in clinical trials and are showing promise. ABC15's Jane Caffery talks to a ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...